The Biological Safety Committee serves as The Institutional Biosafety Committee (IBC) as defined in the National Institutes of Health (NIH) Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. The Committee shall review applications for research involving recombinant DNA to determine whether the facilities, procedures and practices meet the standards required by the University and the NIH. It shall, in addition, have the responsibility to annually certify to the NIH that such facilities, procedures and practices along with the training and expertise of personnel meet NIH standards. Meetings called for the purpose of such review and certification may be open to the public. Minutes of these meetings shall be kept and made available for public inspection.